SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
12 references·16 citing·30 second hop
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens (2011)Multiple receptors contribute to the beha…The neurobiology of psychedelic drugs: implications for the treatment of mood disorders (2010)The neurobiology of psychedel…Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Pilot Study of Psilocybin Tre…Serotonin research: contributions to understanding psychoses (2008)Serotonin research: contribut…Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior (2007)Hallucinogens Recruit Specifi…Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder (2006)Safety, Tolerability, and Eff…Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Psilocybin can occasion mysti…Hallucinogens (2004)HallucinogensPsilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)Psilocybin induces schizophre…Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis (1997)Positron Emission Tomography …Dose-Response Study of N,N-Dimethyltryptamine in Humans (1994)Dose-Response Study of N,N-Di…PIHKAL: A Chemical Love Story (1991)PIHKAL: A Chemical Love StoryEvidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents (1984)Evidence for 5-HT2 involvemen…Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review (2022)Pharmacological, neural, and …The Therapeutic Potential of Psilocybin (2021)The Therapeutic Potential of …Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice (2021)Harnessing psilocybin: antide…Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species (2020)Correlation between the poten…Microdosing psychedelics: More questions than answers? An overview and suggestions for future research (2019)Microdosing psychedelics: Mor…The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act (2018)The abuse potential of medica…Effect of Psilocybin on Empathy and Moral Decision-Making (2017)Effect of Psilocybin on Empat…Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA (2016)Novel psychopharmacological t…The hallucinogenic world of tryptamines: an updated review (2015)The hallucinogenic world of t…Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs) (2015)Receptor interaction profiles…Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences? (2015)Peak experiences and the afte…Recent advances in the neuropsychopharmacology of serotonergic hallucinogens (2014)Recent advances in the neurop…LSD enhances suggestibility in healthy volunteers (2014)LSD enhances suggestibility i…Psilocybin – Summary of knowledge and new perspectives (2013)Psilocybin – Summary of knowl…Characterization of the head-twitch response induced by hallucinogens in mice (2013)Characterization of the head-…Head‐twitch response in rodents induced by the hallucinogen 2,5‐dimethoxy‐4‐iodoamphetamine: a comprehensive history, a re‐evaluation of mechanisms, and its utility as a model (2012)Head‐twitch response in roden…Development of the Addiction Research Center Inventory (ARCI): Selection of items that are sensitive to the effects of various drugs (1963)Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. (1987)Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics (2003)Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects (2014)Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory (2019)The Yale-Brown Obsessive Compulsive Scale (1989)World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision (2008)The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future (2017)"A Controlled Study" (1966)Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function (2018)Psychedelics and Psychedelic-Assisted Psychotherapy (2020)"Mysticism and Philosophy" (1960)Psychedelics (2016)Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (2020)Mysticism and Philosophy (2024)An Inventory for Measuring Depression (1961)The Brief Psychiatric Rating Scale (1962)Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (2012)Diagnostic and Statistical Manual of Mental Disorders (2013)Psychedelics Promote Structural and Functional Neural Plasticity (2018)REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019)Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (2008)Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017)Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders (2020)Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo (2021)Broadband Cortical Desynchronization Underlies the Human Psychedelic State (2013)Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution (2016)Psychedelics as anti-inflammatory agents (2018)Human hallucinogen research: guidelines for safety (2008)
this work references cited by second hop

References

  • 2006Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance1,682 cited
  • 2004Hallucinogens1,208 cited
  • 2010Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer1,205 cited
  • 1998Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action1,015 cited
  • 2007Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior922 cited
  • 2006Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder789 cited
  • 2010The neurobiology of psychedelic drugs: implications for the treatment of mood disorders720 cited
  • 1991PIHKAL: A Chemical Love Story669 cited
  • 1984Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents631 cited
  • 1994Dose-Response Study of N,N-Dimethyltryptamine in Humans454 cited
  • 1997Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis444 cited
  • 2008Serotonin research: contributions to understanding psychoses427 cited

Cited by

  • 2021Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice378 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2018
The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
353 cited
  • 2014LSD enhances suggestibility in healthy volunteers318 cited
  • 2014Recent advances in the neuropsychopharmacology of serotonergic hallucinogens311 cited
  • 2015The hallucinogenic world of tryptamines: an updated review291 cited
  • 2020Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species276 cited
  • 2013Psilocybin – Summary of knowledge and new perspectives275 cited
  • 2015Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?261 cited
  • 2021The Therapeutic Potential of Psilocybin243 cited
  • 2016Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA239 cited
  • 2012Head‐twitch response in rodents induced by the hallucinogen 2,5‐dimethoxy‐4‐iodoamphetamine: a comprehensive history, a re‐evaluation of mechanisms, and its utility as a model221 cited
  • 2022Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review220 cited
  • 2015Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)217 cited
  • 2019Microdosing psychedelics: More questions than answers? An overview and suggestions for future research215 cited
  • 2013Characterization of the head-twitch response induced by hallucinogens in mice214 cited
  • 2017Effect of Psilocybin on Empathy and Moral Decision-Making197 cited